Axcella Health Inc.
Compositions and methods for the treatment of hemoglobinopathies and thalassemias

Last updated:

Abstract:

This disclosure provides compositions and methods for improving erythrocyte dysfunction or treating a hemoglobinopathy or a thalassemia (e.g., sickle cell disease or .beta.-thalassemia).

Status:
Grant
Type:

Utility

Filling date:

19 Jun 2019

Issue date:

13 Jul 2021